Henry Hall

PHD Doctor of Philosophy,  CharitĂ© - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Admin and Customer Support Hospital-Pharmacy-Insurance Grant Submission Legal Support

Areas Of Interest

Slow Wave Sleep Syndromes, Actinic Reticuloid Pretectum Fendiline Nucleotide, Triphosphopyridine Interfaces, Bone-Implant Gemfibrozil, Healthsense Inhibitors, Pancreatic alpha-Amylase Switch Region, Ig CCL7, Chemokine Blue-Sensitive Cone Opsins Sixth Cranial Nerve Disorders SHC Transforming Protein 1 Fossil Fuels X Linked SEDT Chloroquine Dithionite, Sodium Platelet Alloantigens Self Curing of Dental Resins Gay Mannose-Binding Lectin Complement Pathway Estradiol 17beta Cytidine Kinase Hypothalamic Releasing Factor

Professional Narrative

Dr. Henry Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1990
Medical Writer, Mayo Clinic 2002

Education

Master of Science in physician assistant, Weill Medical College 1991
Director Medicine, Harvard Medical School 2010

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :